Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Amgen to Cut More U.S. Jobs

Amgen filed a Worker Adjustment and Retraining in California with plans to cut 172 jobs at the company’s headquarters and U.S. field operations effective December 31, 2019.

Read More »

California sues e-cigarette maker Juul

The state of California sued Juul Labs Inc., alleging the e-cigarette maker engaged in a “systematic” and “wildly successful” campaign to attract teenagers to the San Francisco company’s nicotine devices.

Read More »

Novartis Cuts 150 Jobs, Shifts Focus of Shanghai Facility to Drug Development

Three years after Novartis opened a $1 billion research & development facility in Shanghai, the company is shifting the focus of the site from drug discovery to commercial development.

Read More »

Oklahoma judge reduces J&J opioid payout

An Oklahoma judge said Johnson & Johnson must pay that state $465 million for fueling the opioid epidemic through the deceptive marketing of painkillers, down from his original award of $572 million.

Read More »

Novartis sickle cell drug gets U.S. FDA approval

Novartis AG won U.S. approval for the company’s experimental sickle cell disease drug Adakveo.

Read More »

Mylan Manufacturing Site Flagged for Poor Controls

Mylan has come under fire from the U.S. Food and Drug Administration over inadequate good manufacturing practices at one of the company’s drug manufacturing facilities in India.

Read More »

J&J files for European approval of Ebola vaccine

Johnson & Johnson filed for an approval from European regulators for the company’s two-dose experimental vaccine to protect against Ebola.

Read More »

Bio-Thera gets approval for Humira biosimilar in China

China’s Bio-Thera Solutions Ltd. won a regulatory approval for the company’s version of AbbVie Inc.’s blockbuster rheumatoid arthritis treatment Humira, paving the way for the first such biosimilar to enter the world’s second-largest drug market.

Read More »

Abbott Announces Discovery of New Strain of HIV

A team of Abbott scientists identified a new subtype of the human immunodeficiency virus, called HIV-1 Group M, subtype L.

Read More »

AstraZeneca Backs $1 Billion Fund to Support China’s Growing Pharma Market

AstraZeneca is significantly expanding the company’s footprint in China with the establishment of a global R&D center and launch of a $1 billion fund aimed at supporting that nation’s healthcare sector.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom